Systematix Institutional Equities
-
Why Is Allied Blenders Stock Poised For Re-Rating? Read Systematix Report
Allied Blenders remains a compelling growth story, underpinned by strong manufacturing capabilities, an expanding premium portfolio and improving margins, according to Systematix.
-
Nestle India's Rich Valuations Weigh on Outlook, Says Systematix — Check Target Price, Rating, Upside And More
While Nestle's current growth trajectory is at a multi-year high and on-ground trends are broadly positive, growth could decelerate in H2 FY27, highlights Systematix
-
Metals, Minings Stocks To Buy: NMDC, JSW Steel, APL Apollo Among Systematix's Top Picks Post Q4 — Check Full List
In mining, NMDC emerged as the strongest performer aided by 21% YoY volume growth and higher iron ore price.
-
NMDC: 21% Upside Seen as Systematix Raises Target Price Post Q4 Results — Check Key Triggers
Long-term growth levers, including capacity expansion, improving logistics, ramp-up in coal assets and increased focus on value-added products are expected to support NMDC's earnings visibility over the medium term, says Systematix.
-
Suzlon Energy in Focus; Target Price Revised as Systematix Remains Bullish After Q4 Results — Check Upside
Systematix remain positive on Suzlon Energy given its market leadership reflecting a pivotal role in accelerating wind capacity addition in India, improving execution, and increasing strategic focus on EPC, hybrid, and FDRE projects.
-
Hindalco's Target Price Revised After Q4 Results; Systematix Maintain 'Hold' Rating — Check Upside
Systematix has revised its FY27/FY28 Ebitda estimates on Hindalco upward by 14%/7%, primarily driven by improved assumptions for aluminium downstream margins, higher commodity price assumptions, and a gradual recovery in Novelis margins and shipments.
-
Indraprastha Gas Shares In Focus As Systematix Revises Target Price After Q4 Results — Check Upside
IGL reported healthy volume growth in Q4 offset by softer margins amid rising gas cost and increased opex, says the brokerage.
-
Max Financial Services Delivers on VNB Margin, Growth Guidance, Says Systematix; Maintains Bullish Call After Q4 Results — Check Target Price
MAX Financial Services has posted a strong annual premium equivalent growth for the March quarter of 31.5% QoQ and 18.3% YoY and stood at Rs 3,590 crore.
-
Berger Paints in Focus as Systematix Retains Buy After Strong Q4 — Check Target Price
Despite the price hikes, management expects volume growth to remain largely resilient, expecting to retain FY26 growth levels, consequently, Berger Paints sees the volume-value gap reversing to positive in FY27 with the price-demand elasticity playing out.
-
Lupin Target Price Cut By Systematix After Q4 Results — Should You Buy, Sell Or Hold?
The near-term earnings growth may be a challenge for Lupin as they should see impact of competition in their largest portfolio product, gTolvaptan in FY27, adds the brokerage.
-
Shree Cement Gets Rating Upgrade After Q4 Results On Favorable Valuations — Check Target Price
Shree Cement remains well-positioned with strong volume growth and ongoing capacity expansion, though near-term margins may stay under pressure due to elevated costs, says Systematix.
-
Marico Q4 Review: Systematix Ups Target Price on Double-Digit Growth Outlook — Should You Buy?
Systematix maintains its bullish call on Marico and the stock remains its preferred pick in the sector.
-
HUL: Systematix Turns Cautious on Valuations, Cuts Target Price Post Q4 Results — Check Potential Upside
The fmcg major delivered a strong Q4 performance, with consolidated revenue rising 8% YoY, the highest growth in 12 quarters, supported by 6% volume growth led by home care, hair care and premium personal care segments.
-
Jana Small Finance Bank Shares In Focus As Systematix Revises Target Price After Q4 Results — Check Potential Upside
Sutained execution and consistent delivery on stated metrics will be critical for any meaningful re-rating of Jana Small Finance Bank, says the brokerage.
-
Canara HSBC Life Insurance Shares In Focus As Systematix Revises Target Price After Q4 Results — Check Potential Upside
Canara HSBC Life Insurance's calculated Q4 FY26 value of new business came in at Rs 210 crore (21.4% higher than estimates) up by 8.0% QoQ and 48.7% YoY.
